P. Rojo

Increment of immunogenicity after third dose of a homologous inactivated SARS-CoV-2 vaccine in a large population of patients with autoimmune rheumatic diseases

E. Bonfá, R. Fuller, S. Pasoto, 2022, Annals of the Rheumatic Diseases.

Immunogenicity and safety of the CoronaVac inactivated vaccine in patients with autoimmune rheumatic diseases: a phase 4 trial

Solange R. G. Fusco, E. Bonfá, S. Shinjo, 2021, Nature Medicine.

Immunogenicity and safety of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseases

Solange R. G. Fusco, E. Bonfá, S. Shinjo, 2021 .